Catalyst Pharmaceuticals Files Q1 2025 10-Q
Ticker: CPRX · Form: 10-Q · Filed: May 7, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials, royalty
Related Tickers: CPRX
TL;DR
Catalyst Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Catalyst Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business operations. Key financial details and operational highlights are presented in this filing, which covers the first quarter of 2025.
Why It Matters
This filing provides investors with an update on Catalyst Pharmaceuticals' financial health and operational progress during the first quarter of 2025, impacting investment decisions.
Risk Assessment
Risk Level: medium — The company operates in the pharmaceutical industry, which is subject to significant regulatory, research, and market risks.
Key Numbers
- More than $500 million and less than $750 million — Royalty (Potential royalty payment range)
- More than $10 million and less than $100 million — Royalty (Potential royalty payment range)
- More than $250 million and less than $500 million — Royalty (Potential royalty payment range)
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250507 (date) — Filing Date
- 355 ALHAMBRA CIRCLE (address) — Business Address
- CORAL GABLES (city) — Business Address City
- FL (state) — Business Address State
- 33134 (zip_code) — Business Address Zip
- RoyaltyMoreThanFiveHundredMillionAndLessThanSevenHundredFiftyMillionMember (financial_metric) — Royalty amount category
- AgamreeMember (entity) — Related to royalty payments
- U.s.RightsForFycompaMember (entity) — Related to US rights for Fycopa
FAQ
What is the reporting period for this 10-Q filing?
The reporting period is for the quarter ended March 31, 2025.
What is the company's primary business address?
The company's business address is 355 Alhambra Circle, Suite 801, Coral Gables, FL 33134.
What is the SIC code for Catalyst Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834, for Pharmaceutical Preparations.
What specific royalty payment ranges are mentioned in the filing?
The filing mentions royalty ranges of 'More Than Five Hundred Million And Less Than Seven Hundred Fifty Million', 'More Than Ten Million And Less Than Hundred Million', and 'More Two Hundred And Fifty Million And Less Than Five Hundred Million'.
When did Catalyst Pharmaceuticals, Inc. have a public offering?
A public offering is noted with the date 2024-01-09.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).